What is the current Price Target for the Bioline RX Ltd Sponsored ADR stock?

The average Bioline RX Ltd Sponsored ADR target price is $26.00. This is 1,001.69% higher than the current stock price. The highest price target is 1,594.92%, the lowest is 408.47%. 3 Analysts have issued a price target Bioline RX Ltd Sponsored ADR 2027 .

How high will the Bioline RX Ltd Sponsored ADR stock rise?

No reliable answer can be given as to how high the Bioline RX Ltd Sponsored ADR stock will rise. The performance of stocks, including the Bioline RX Ltd Sponsored ADR stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Bioline RX Ltd Sponsored ADR stock today?

The performance of Bioline RX Ltd Sponsored ADR stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Bioline RX Ltd Sponsored ADR stock fall?

The decline in Bioline RX Ltd Sponsored ADR stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Bioline RX Ltd Sponsored ADR Forecast, price target & analysts

$2.36

2.88%

Nasdaq, Sep 29, 04:00 pm EDT. Closed.

ISIN

US09071M1062

Symbol

BLRX

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Overview Analysts Charts Ownership News Strategies

Bioline RX Ltd Sponsored ADR Target price 2026 - Analyst rating & recommendation

Bioline RX Ltd Sponsored ADR Price Target

Target Price	$26.00
Price	$2.36
Potential	1,001.69% register free of charge
Number of Estimates	3

	3 Analysts have issued a price target Bioline RX Ltd Sponsored ADR 2027 . The average Bioline RX Ltd Sponsored ADR target price is $26.00. This is 1,001.69% register free of charge higher than the current stock price. The highest price target is $40.00 1,594.92% register free of charge , the lowest is $12.00 408.47% register free of charge .
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Bioline RX Ltd Sponsored ADR stock has an average upside potential 2027 of 1,001.69% register free of charge .

Sales and Margin forecast 2026, 2027 to 2029

Create a premium account to unlock analyst estimates. Learn more

Annually

	Dec '25	2026 Estimates
Revenue Million $	1.18	7.27
	95.92%	516.44%
Net Margin	-172.03%	0.00%
	439.98%	100.00%

2 Analysts have issued a sales forecast Bioline RX Ltd Sponsored ADR 2026 . The average Bioline RX Ltd Sponsored ADR sales estimate is

unlock

. This is

unlock

than the revenue of the last 12 months(TTM). The highest sales forecast is

unlock

, the lowest is

unlock

This results in the following potential growth metrics:

2025	$1.2m	95.92%
2026	$7.3m 516.44% unlock
2027	$11.3m 55.29% unlock
2028	$13.7m 21.24% unlock
2029	$18.5m 35.03% unlock

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2029

Create a premium account to unlock analyst estimates. Learn more

Annually

	Dec '25	2026 Estimates
Earnings Per Share $	0.00	0.00
	100.00%
EV/Sales		0.74

Based on analysts' sales estimates for 2026, the Bioline RX Ltd Sponsored ADR stock is valued at an EV/Sales of

unlock

and an P/S ratio of

unlock

This results in the following potential growth metrics and future valuations:

Current	1.64	993.33%
2026	0.74 54.82% unlock
2027	0.48 35.60% unlock
2028	0.39 17.52% unlock
2029	0.29 25.94% unlock

Current	10.73	1,398.34%
2026	2.48 76.91% unlock
2027	1.60 35.60% unlock
2028	1.32 17.52% unlock
2029	0.97 25.95% unlock

Bioline RX Ltd Sponsored ADR...

Current Bioline RX Ltd Sponsored ADR Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
HC Wainwright & Co.	Locked ➜ Locked	Locked	Jun 17 2025
Jones Trading	Locked ➜ Locked	Locked	May 30 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	May 28 2025

Analyst Rating	Date
Locked HC Wainwright & Co.: Locked ➜ Locked	Jun 17 2025
Locked Jones Trading: Locked ➜ Locked	May 30 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	May 28 2025

Discover more stocks with a high price target

NIO ADR 115.40%

Alibaba Group Holding Ltd 73.67%

Rheinmetall 69.93%

Tencent Holdings Ltd. 58.19%

Infineon 55.67%

Adyen 54.76%

BYD 51.64%

Uber Technologies 48.53%

TUI 47.22%

Siemens Energy 43.40%

Adidas 43.11%

Deutsche Telekom 41.02%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now